Solstein Capital’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-1,359
| Closed | -$401K | – | 438 |
|
|
2026
Q1 | $401K | Buy |
1,359
+316
| +30% | +$93.9K | 0.16% | 97 |
|
|
2025
Q4 | $285K | Sell |
1,043
-65
| -6% | -$17.7K | 0.11% | 110 |
|
|
2025
Q3 | $299K | Hold |
1,108
| – | – | 0.07% | 102 |
|
|
2025
Q2 | $305K | Buy |
1,108
+287
| +35% | +$78K | 0.16% | 93 |
|
|
2025
Q1 | $218K | Hold |
821
| – | – | 0.13% | 94 |
|
|
2024
Q4 | $191K | Hold |
821
| – | – | 0.11% | 101 |
|
|
2024
Q3 | $181K | Hold |
821
| – | – | 0.1% | 106 |
|
|
2024
Q2 | $161K | Hold |
821
| – | – | 0.11% | 104 |
|
|
2024
Q1 | $177K | Sell |
821
-7
| -0.8% | -$1.47K | 0.12% | 94 |
|
|
2023
Q4 | $174K | Hold |
828
| – | – | 0.13% | 96 |
|
|
2023
Q3 | $166K | Hold |
828
| – | – | 0.14% | 89 |
|
|
2023
Q2 | $153K | Hold |
828
| – | – | 0.13% | 95 |
|
|
2023
Q1 | $159K | Sell |
828
-7
| -0.8% | -$1.27K | 0.14% | 94 |
|
|
2022
Q4 | $140K | Buy |
835
+615
| +280% | +$107K | 0.12% | 115 |
|
|
2022
Q3 | $39K | Hold |
220
| – | – | 0.03% | 166 |
|
|
2022
Q2 | $45K | Hold |
220
| – | – | 0.03% | 180 |
|
|
2022
Q1 | $52K | Sell |
220
-635
| -74% | -$149K | 0.03% | 187 |
|
|
2021
Q4 | $195K | Hold |
855
| – | – | 0.12% | 126 |
|
|
2021
Q3 | $165K | Buy |
855
+718
| +524% | +$145K | 0.09% | 144 |
|
|
2021
Q2 | $29K | Hold |
137
| – | – | 0.04% | 261 |
|
|
2021
Q1 | $28K | Buy |
+137
| New | +$27K | 0.04% | 236 |
|
|
2020
Q4 | – | Sell |
-137
| Closed | -$23K | – | 110 |
|
|
2020
Q3 | $23K | Hold |
137
| – | – | 0.05% | 170 |
|
|
2020
Q2 | $22K | Hold |
137
| – | – | 0.05% | 164 |
|
|
2020
Q1 | $24K | Buy |
137
+7
| +5% | +$1.39K | 0.09% | 123 |
|
|
2019
Q4 | $26K | Buy |
+130
| New | +$26.7K | 0.05% | 164 |
|
|
2019
Q2 | – | Sell |
-1,630
| Closed | -$268K | – | 37 |
|
|
2019
Q1 | $268K | Hold |
1,630
| – | – | 1.51% | 23 |
|
|
2018
Q4 | $307K | Sell |
1,630
-1,500
| -48% | -$277K | 1.79% | 15 |
|
|
2018
Q3 | $533K | Sell |
3,130
-800
| -20% | -$135K | 2.94% | 12 |
|
|
2018
Q2 | $644K | Hold |
3,930
| – | – | 3.03% | 12 |
|
|
2018
Q1 | $636K | Buy |
+3,930
| New | +$626K | 2.14% | 18 |
|
Other funds holding CME
Solstein Capital's CME Position: Q2 2026 in Review
Solstein Capital sold out of CME Group (CME) in Q2 2026, closing a stake of 1,359 shares — an estimated $401K sold.
Solstein Capital first reported a position in CME in Q1 2018 and held it in 30 quarters. The position peaked at $644K in Q2 2018. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Solstein Capital reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
- Solstein Capital sold 1,359 CME Group shares in Q2 2026, an estimated $401K.
- Solstein Capital first reported a position in CME Group in Q1 2018 and held it in 30 quarters.
- Solstein Capital's CME Group position peaked at $644K in Q2 2018.
- 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Solstein Capital's 13F filing for Q2 2026, filed 13 Aug 2026.